Astex has built a rich product portfolio with multiple drugs in preclinical and clinical development.
We also have a number of partnered products being developed under our collaboration and license agreements with major pharmaceutical companies including three approved drugs that are now on the market.
Latest from Astex
In the News
Harren Jhoti, Astex Pharmaceuticals President and CEO jointly wins Executive of the Year Award (Commercial-Stage Companies) at Scrip Awards
Novartis Kisqali® receives European Commission approval in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence
Astex wins the Research and Development Achievement Award at the Pharma Awards
Sustaining Innovation
Sustaining Innovation Postdoctoral Training Program
Career Opportunities
We seek to attract and retain talented individuals who are passionate about improving patient outcomes.
© Astex Pharmaceuticals
All rights reserved
